Am J Transplant, Volume 18, Suppl 3 Archives - Page 20 of 211 - ATC Abstracts

2018 American Transplant Congress
Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients
E. Tang, A. Bansal, S. Cao, M. Li, M. Novak, I. Mucsi.
University Health Network, Toronto, Canada.
Background: The Patient Reported Outcomes Measurement Information System (PROMIS) provides generalizable and universal measures of various domains of patient reported outcomes. The PROMIS-57 and PROMIS-29…
2018 American Transplant Congress
A Theoretical Framework to Explain Factors That Impact Completion of the Medical Evaluation Process for African American (AA) End-Stage Renal Disease (ESRD) Patient
C. Nonterah,¹ H. Gardiner,² D. Vavra.¹
¹Psychology, University of Richmond, Richmond, VA; ²Department of Social and Behavioral Sciences, Temple University, Philadelphia, PA.
Black/African Americans (B/AA) are less likely to seek kidney transplantation or complete the pre-transplant medical evaluation despite higher prevalence rates of end-stage renal disease (ESRD).…
2018 American Transplant Congress
Long-Term Efficacy and Safety of Prolonged-Release Tacrolimus in Stable Pediatric Allograft Recipients Converted from Immediate-Release Tacrolimus
N. Undre,¹ J. Rubik,² D. Debray,³ D. Kelly,⁴ F. Iserin,⁵ N. Webb,⁶ P. Czubkowski,² K. Vondrak,⁷ A-.L. Sellier-Leclerc,⁸ S. Riva,⁹ B. Tönshoff,¹⁰ L. D'Antiga,¹¹ S. Marks,¹² R. Reding,¹³ G. Kazeem.¹
¹Astellas Pharma Europe Ltd, Chertsey, United Kingdom; ²Children's Memorial Health Institute, Warsaw, Poland; ³APHP-Hôpital Universitaire Necker, Paris, France; ⁴Birmingham Children's Hospital, Birmingham, United Kingdom; ⁵University Hospital Necker Enfants Malades, Paris, France; ⁶Manchester University Foundation Trust, Manchester, United Kingdom; ⁷University Hospital Motol, Prague, Czech Republic; ⁸Hôpital Femme-Mère-Enfant, Bron Cedex, France; ⁹ISMETT-IRCCSS, Palermo, Italy; ¹⁰University Children's Hospital, Heidelberg, Germany; ¹¹Hospital Papa Giovanni XXIII, Bergamo, Italy; ¹²Great Ormond Street Hospital for Children, London, United Kingdom; ¹³Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium.
Study assessed long-term efficacy/safety of prolonged-release tacrolimus (PR-T) in stable solid organ allograft recipients (aged 5–16 yrs) who participated in a multicenter, Phase II pharmacokinetics…
2018 American Transplant Congress
Large Volume Intraoperative Fluid Use in Small (<20kg) Renal Recipients is Safe
N. Liow,¹ N. Mudalige,² N. Melhem,¹ S. Boyle,¹ N. Kessaris,¹ H. Hume-Smith,¹ S. Marks,¹ N. Mamode,¹ J. Stojanovic.¹
¹Paediatric Nephrology Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; ²University College London, London, United Kingdom.
INTRODUCTION: With advances in surgical and medical transplantation, progressively younger children are being transplanted. There is no consensus and little evidence on the optimal intraoperative…
2018 American Transplant Congress
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients
E. Kincaide,^1,2,3 K. Hitchman,^1,3 R. Hall,^1,2,3 I. Yamaguchi,³ B. Crowther.^1,2,3
¹University Health System, San Antonio, TX; ²College of Pharmacy, Pharmacotherapy Division, The University of Texas at Austin, San Antonio, TX; ³UT Health San Antonio, San Antonio, TX.
Purpose: Evaluate the efficacy and safety of acute antibody mediated rejection (AMR) treatment modalities in pediatric kidney transplant recipients (KTR).Methods: A single-center retrospective chart review…
2018 American Transplant Congress
Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver
M. Decoteau,¹ P. Lewis,¹ S. Steuterman,² R. Schaffer,¹ J. Fisher,¹ J. Case,¹ C. Marsh.¹
¹Organ Transplantation, Scripps Green Hospital, La Jolla, CA; ²Medical Physics & Radiation Safety, Scripps Green Hospital, La Jolla, CA.
BACKGROUND: Yttrium-90 (Y-90) radioembolization for the treatment of hepatocellular carcinoma can present safety challenges to the surgeon when transplanting a recently treated Y-90 patient. To…
2018 American Transplant Congress
The Impact of Rapamycin Conversion in Pediatric Liver Transplantation on Anti-HLA Antibody Formation and Allograft Fibrosis
R. Fischer,² L. Fromm,¹ J. Daniel,² A. Kats,² R. Hendrickson,² W. Andrews.²
¹University of Kansas College of Medicine, Kansas City, KS; ²Children's Mercy Hospital, Kansas City, MO.
Background: Maintenance immunosuppression with tacrolimus (TAC) is associated with progressive liver allograft fibrosis. Conversion to rapamycin (RAPA) may abrogate this progression. The development of donor-specific…
2018 American Transplant Congress
Why the Low Usage of HIV Positive Donors? A Survey of the Transplant Community
S. Nazarian,¹ C. Watts,² D. Sawinski,² P. Reese,² D. Goldberg,² P. Abt,¹ S. Halpern,² J. Shea,² E. Blumberg.²
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Medicine, University of Pennsylvania, Philadelphia, PA.
BackgroundSince the HIV Policy Equity Act of 2013, 22 programs have been approved to use HIV+ kidneys and livers, yet these transplants remain uncommon. It…
2018 American Transplant Congress
Procurement Travel Safety: Current Practices, Accident Frequency, Perceptions of Safety and Means to Reduce Risk
A. Schenk, A. Adams, R. Lynch.
Emory Transplant Center, Emory University, Atlanta, GA.
Transplant procurement teams travel extensively. Though considered hazardous, little data on the necessity and risks of this travel exist. We conducted a survey of ASTS…
2018 American Transplant Congress
Organ Transplant Abuse in China (2): Continued Growth after Gaining International Attention
G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
¹China Organ Harvest Research Center, Middletown, NY; ²MD Anderson Cancer Center, University of Texas, Houston, TX.
PurposeThe government of China has responded to allegations that China has been harvesting organs from prisoners of conscience in extrajudicial killings on a large scale…